The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy

The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy

CTC levels collected pre-surgery will be correlated with pathological samples.

Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will collect demographic and treatment data and explore & describe the pattern of CTC detection in all patients

Inclusion Criteria:

• Patients with biopsy-proven NSCLC who are undergoing definitive radiotherapy as a part of their treatment regimen.
• Age 18 or older
• Signed informed consent
• Patients who are incapable of providing informed consent are excluded from participating in this study.